全球保守性肾脏管理的可及性与质量
本研究基于国际肾脏病学会2022年全球肾脏健康调查,评估165个国家保守性肾脏管理(CKM)的服务可及性与资金情况。结果显示61%的国家提供某种形式的CKM,但CKM的定义和内容差异大,且资源匮乏地区CKM可及性不足,导致未满足的姑息治疗需求。
要点
- 165个国家中61%报告可提供某种形式的CKM。
- 通过共享决策选择的CKM在53%国家可及,因无法获得KRT而被迫选择的CKM在39%国家可及。
- 疼痛与姑息治疗必需药物仅在略超半数国家可及,且高度依赖收入水平。
核心结论
- 多数国家报告具备一定的CKM能力,但CKM的定义、内容及提供量存在显著差异。
- CKM可及性差导致姑息治疗需求未满足,在资源匮乏地区尤为突出。
研究设计与样本
- 数据来自国际肾脏病学会2022年6月至9月进行的全球肾脏健康调查。
- 评估了165个应答国家的CKM可及性、基础设施、指南、药物和培训情况。
主要发现
- CKM以某种形式在61%的165个应答国家可及。
- 通过共享决策选择的CKM在53%国家可及;因无法获得KRT而被迫选择的CKM在39%国家可及。
- 通过共享决策选择的CKM的基础设施“普遍可及”在高收入国家为71%、中高收入国家为50%、中低收入国家为33%、低收入国家为42%。
- 被迫选择的CKM的基础设施“普遍可及”在高收入国家为29%、中高收入国家为50%、中低收入国家为67%、低收入国家为58%。
- 疼痛与姑息治疗必需药物在略超半数国家可及,且高度依赖收入水平;照护者症状管理培训在约三分之一国家可及。
临床怎么用
- 肾内科医生应评估患者是否适合CKM,并通过共享决策提供支持性照护。
- 在资源有限地区,需关注CKM所需的疼痛与姑息治疗药物可及性及照护者培训。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Conservative kidney management (CKM) describes supportive care for people living with kidney failure who choose not to receive or are unable to access kidney replacement therapy (KRT). This study captured the global availability of CKM services and funding. METHODS: Data came from the International Society of Nephrology Global Kidney Health survey conducted between June and September 2022. Availability of CKM, infrastructure, guidelines, medications and training were evaluated. RESULTS: CKM was available in some form in 61% of the 165 responding countries. CKM chosen through shared decision-making was available in 53%. Choice-restricted CKM-for those unable to access KRT-was available in 39%. Infrastructure to provide CKM chosen through shared decision-making was associated with national income level, reported as being "generally available" in most healthcare settings for 71% of high-income countries, 50% of upper-middle-income countries, 33% of lower-middle-income countries and 42% of low-income countries. For choice-restricted CKM, these figures were 29%, 50%, 67% and 58%, respectively. Essential medications for pain and palliative care were available in just over half of the countries, highly dependent upon income setting. Training for caregivers in symptom management in CKM was available in approximately a third of countries. CONCLUSIONS: Most countries report some capacity for CKM. However, there is considerable variability in terms of how CKM is defined, as well as what and how much care is provided. Poor access to CKM perpetuates unmet palliative care needs, and must be addressed, particularly in low-resource settings where death from untreated kidney failure is common.
引用
- Hole B, Wearne N, Arruebo S, et al. Global access and quality of conservative kidney management. Nephrol Dial Transplant. 2024. PMID: 39235199. doi:10.1093/ndt/gfae129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。